BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 18222471)

  • 1. Stabilization of the human beta2-adrenergic receptor TM4-TM3-TM5 helix interface by mutagenesis of Glu122(3.41), a critical residue in GPCR structure.
    Roth CB; Hanson MA; Stevens RC
    J Mol Biol; 2008 Mar; 376(5):1305-19. PubMed ID: 18222471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
    Bhattacharya S; Hall SE; Vaidehi N
    J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of G protein-selective G protein-coupled receptor (GPCR) conformations in live cells.
    Malik RU; Ritt M; DeVree BT; Neubig RR; Sunahara RK; Sivaramakrishnan S
    J Biol Chem; 2013 Jun; 288(24):17167-78. PubMed ID: 23629648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand-stabilized conformational states of human beta(2) adrenergic receptor: insight into G-protein-coupled receptor activation.
    Bhattacharya S; Hall SE; Li H; Vaidehi N
    Biophys J; 2008 Mar; 94(6):2027-42. PubMed ID: 18065472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural studies of the putative helix 8 in the human beta(2) adrenergic receptor: an NMR study.
    Katragadda M; Maciejewski MW; Yeagle PL
    Biochim Biophys Acta; 2004 May; 1663(1-2):74-81. PubMed ID: 15157609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the NPxxY motif stabilize pharmacologically distinct conformational states of the α
    Ragnarsson L; Andersson Å; Thomas WG; Lewis RJ
    Sci Signal; 2019 Mar; 12(572):. PubMed ID: 30862702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dynamics of a biophysical model for beta2-adrenergic and G protein-coupled receptor activation.
    Rubenstein LA; Zauhar RJ; Lanzara RG
    J Mol Graph Model; 2006 Dec; 25(4):396-409. PubMed ID: 16574446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural insights into agonist-induced activation of G-protein-coupled receptors.
    Deupi X; Standfuss J
    Curr Opin Struct Biol; 2011 Aug; 21(4):541-51. PubMed ID: 21723721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity.
    Sanchez-Soto M; Verma RK; Willette BKA; Gonye EC; Moore AM; Moritz AE; Boateng CA; Yano H; Free RB; Shi L; Sibley DR
    Sci Signal; 2020 Feb; 13(617):. PubMed ID: 32019899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-Based Sequence Alignment of the Transmembrane Domains of All Human GPCRs: Phylogenetic, Structural and Functional Implications.
    Cvicek V; Goddard WA; Abrol R
    PLoS Comput Biol; 2016 Mar; 12(3):e1004805. PubMed ID: 27028541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FoldGPCR: structure prediction protocol for the transmembrane domain of G protein-coupled receptors from class A.
    Michino M; Chen J; Stevens RC; Brooks CL
    Proteins; 2010 Aug; 78(10):2189-201. PubMed ID: 20544957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active state-like conformational elements in the beta2-AR and a photoactivated intermediate of rhodopsin identified by dynamic properties of GPCRs.
    Han DS; Wang SX; Weinstein H
    Biochemistry; 2008 Jul; 47(28):7317-21. PubMed ID: 18558776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in conformation at the cytoplasmic ends of the fifth and sixth transmembrane helices of a yeast G protein-coupled receptor in response to ligand binding.
    Umanah GK; Huang LY; Maccarone JM; Naider F; Becker JM
    Biochemistry; 2011 Aug; 50(32):6841-54. PubMed ID: 21728340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantifying conformational changes in GPCRs: glimpse of a common functional mechanism.
    Dalton JA; Lans I; Giraldo J
    BMC Bioinformatics; 2015 Apr; 16(1):124. PubMed ID: 25902715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PheVI:09 (Phe6.44) as a sliding microswitch in seven-transmembrane (7TM) G protein-coupled receptor activation.
    Valentin-Hansen L; Holst B; Frimurer TM; Schwartz TW
    J Biol Chem; 2012 Dec; 287(52):43516-26. PubMed ID: 23135271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Light-driven activation of beta 2-adrenergic receptor signaling by a chimeric rhodopsin containing the beta 2-adrenergic receptor cytoplasmic loops.
    Kim JM; Hwa J; Garriga P; Reeves PJ; RajBhandary UL; Khorana HG
    Biochemistry; 2005 Feb; 44(7):2284-92. PubMed ID: 15709741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and functional roles of small group-conserved amino acids present on helix-H7 in the β(2)-adrenergic receptor.
    Arakawa M; Chakraborty R; Upadhyaya J; Eilers M; Reeves PJ; Smith SO; Chelikani P
    Biochim Biophys Acta; 2011 Apr; 1808(4):1170-8. PubMed ID: 21262196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A highly conserved tryptophan residue in the fourth transmembrane domain of the A adenosine receptor is essential for ligand binding but not receptor homodimerization.
    Suzuki T; Namba K; Yamagishi R; Kaneko H; Haga T; Nakata H
    J Neurochem; 2009 Aug; 110(4):1352-62. PubMed ID: 19558453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fourth transmembrane segment of the dopamine D2 receptor: accessibility in the binding-site crevice and position in the transmembrane bundle.
    Javitch JA; Shi L; Simpson MM; Chen J; Chiappa V; Visiers I; Weinstein H; Ballesteros JA
    Biochemistry; 2000 Oct; 39(40):12190-9. PubMed ID: 11015197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive activation of G protein-coupled receptors as a result of selective substitution of a conserved leucine residue in transmembrane helix III.
    Tao YX; Abell AN; Liu X; Nakamura K; Segaloff DL
    Mol Endocrinol; 2000 Aug; 14(8):1272-82. PubMed ID: 10935550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.